Agilon Health Inc (NYSE: AGL) kicked off on Friday, up 1.25% from the previous trading day, before settling in for the closing price of $4.00. Over the past 52 weeks, AGL has traded in a range of $1.50-$7.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 51.05% over the past five years. While this was happening, its average annual earnings per share was recorded 52.13%. With a float of $303.58 million, this company’s outstanding shares have now reached $412.19 million.
Let’s look at the performance matrix of the company that is accounted for 1076 employees. In terms of profitability, gross margin is -0.11%, operating margin of -4.77%, and the pretax margin is -4.11%.
Agilon Health Inc (AGL) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of Agilon Health Inc is 26.37%, while institutional ownership is 71.67%. The most recent insider transaction that took place on Dec 13 ’24, was worth 55,085. In this transaction Director of this company bought 25,000 shares at a rate of $2.20, taking the stock ownership to the 73,166 shares. Before that another transaction happened on Dec 11 ’24, when Company’s Director bought 25,062 for $2.01, making the entire transaction worth $50,269. This insider now owns 66,144 shares in total.
Agilon Health Inc (AGL) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 52.13% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.97% during the next five years compared to 3.29% growth over the previous five years of trading.
Agilon Health Inc (NYSE: AGL) Trading Performance Indicators
Take a look at Agilon Health Inc’s (AGL) current performance indicators. Last quarter, stock had a quick ratio of 1.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.63, a number that is poised to hit 0.00 in the next quarter and is forecasted to reach -0.18 in one year’s time.
Technical Analysis of Agilon Health Inc (AGL)
Agilon Health Inc (NYSE: AGL) saw its 5-day average volume 6.99 million, a positive change from its year-to-date volume of 5.81 million. As of the previous 9 days, the stock’s Stochastic %D was 90.46%. Additionally, its Average True Range was 0.31.
During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 95.15%, which indicates a significant increase from 90.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.56% in the past 14 days, which was lower than the 113.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.25, while its 200-day Moving Average is $3.98. Nevertheless, the first resistance level for the watch stands at $4.19 in the near term. At $4.33, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.49. If the price goes on to break the first support level at $3.90, it is likely to go to the next support level at $3.74. Assuming the price breaks the second support level, the third support level stands at $3.60.
Agilon Health Inc (NYSE: AGL) Key Stats
The company with the Market Capitalisation of 1.67 billion has total of 412,303K Shares Outstanding. Its annual sales at the moment are 6,061 M in contrast with the sum of -260,150 K annual income. Company’s last quarter sales were recorded 1,522 M and last quarter income was -105,790 K.
